Molecular biology of liver ischemia/reperfusion injury: established mechanisms and recent advancements.
about
Mitochondrial Dysfunction and Autophagy in Hepatic Ischemia/Reperfusion InjurySterile inflammation in acute liver injury: myth or mystery?The effect of intravenous anesthetics on ischemia-reperfusion injuryIL-6-mediated activation of Stat3α prevents trauma/hemorrhagic shock-induced liver inflammationDamage-associated molecular pattern-activated neutrophil extracellular trap exacerbates sterile inflammatory liver injury.Regulation of drug-metabolizing enzymes by local and systemic liver injuriesThe TSC complex is required for the benefits of dietary protein restriction on stress resistance in vivoGlobal MicroRNA Expression Profiling of Mouse Livers following Ischemia-Reperfusion Injury at Different StagesInhibition of sphingosine kinase-2 suppresses inflammation and attenuates graft injury after liver transplantation in ratsRegulation of molecular pathways in ischemia-reperfusion injury after liver transplantation.Melatonin treatment enhances therapeutic effects of exosomes against acute liver ischemia-reperfusion injury.Topical Application of Mesenchymal Stromal Cells Ameliorated Liver Parenchyma Damage After Ischemia-Reperfusion Injury in an Animal Model.Hydroxysafflor yellow A attenuates ischemia/reperfusion-induced liver injury by suppressing macrophage activation.Biomarkers distinguish apoptotic and necrotic cell death during hepatic ischemia/reperfusion injury in mice.Novel in vitro model for studying hepatic ischemia-reperfusion injury using liver cubes.Blocking cold-inducible RNA-binding protein protects liver from ischemia-reperfusion injuryEffects of ischemic preconditioning in a pig model of large-for-size liver transplantation2-Acetylcyclopentanone, an enolate-forming 1,3-dicarbonyl compound, is cytoprotective in warm ischemia-reperfusion injury of rat liver.miR-146a ameliorates liver ischemia/reperfusion injury by suppressing IRAK1 and TRAF6.Endogenous histones function as alarmins in sterile inflammatory liver injury through Toll-like receptor 9 in mice.IRF-1 promotes liver transplant ischemia/reperfusion injury via hepatocyte IL-15/IL-15Rα productionButyrate protects rats from hepatic ischemia/reperfusion injury.Mitochondrial Damage-Associated Molecular Patterns (MTDs) Are Released during Hepatic Ischemia Reperfusion and Induce Inflammatory Responses.Estrogen Sulfotransferase Is an Oxidative Stress-responsive Gene That Gender-specifically Affects Liver Ischemia/Reperfusion InjuryPreserving low perfusion during surgical liver blood inflow control prevents hepatic microcirculatory dysfunction and irreversible hepatocyte injury in rats.Anti-CD163-dexamethasone protects against apoptosis after ischemia/reperfusion injuries in the rat liverOrganotypic liver culture models: meeting current challenges in toxicity testing.Nilotinib protects the murine liver from ischemia/reperfusion injury.Hepatocytes express the antimicrobial peptide HBD-2 after multiple trauma: an experimental study in human and mice.Dexmedetomidine alleviates the spinal cord ischemia-reperfusion injury through blocking mast cell degranulationCirculating Fibroblast Growth Factor 21 Is A Sensitive Biomarker for Severe Ischemia/reperfusion Injury in Patients with Liver TransplantationSerial volumetric assessment of large for size liver grafts after whole cadaveric liver transplant in adults: do large liver grafts shrink in size?Adenoviral gene transfer of hepatic stimulator substance confers resistance against hepatic ischemia-reperfusion injury by improving mitochondrial function.N-acetylcysteine administration does not improve patient outcome after liver resection.Interleukin-6 and rs1800796 locus single nucleotide polymorphisms in response to hypoxia/reoxygenation in hepatocytes.Histones activate the NLRP3 inflammasome in Kupffer cells during sterile inflammatory liver injury.Protection of rat liver against hepatic ischemia-reperfusion injury by a novel selenocysteine-containing 7-mer peptideBlocking Notch signal in myeloid cells alleviates hepatic ischemia reperfusion injury by repressing the activation of NF-κB through CYLDImmunity and immune response, pathology and pathologic changes: progress and challenges in the immunopathology of yellow fever.Treating ischaemia-reperfusion injury with prostaglandin E1 reduces the risk of early hepatocellular carcinoma recurrence following liver transplantation.
P2860
Q26771761-B4ECC965-BC41-45B5-9A79-2D78681A4DBFQ26799490-35BCAB82-A9B3-42B1-A768-E5511085CB0CQ27010024-8DBFF19C-F9B5-4228-9BAB-2D15EE145006Q27334414-501EBD45-792F-4AB0-ACCD-EB1EC6ED9966Q27334890-03581FF5-117D-440B-AF30-82DC14643717Q28067682-96B6BDD9-3D17-4963-93EE-1997F1B32408Q28246133-2E5E11A1-015C-41D8-8B78-2D5A14CEC51FQ28550049-0F6CE52F-A685-43EF-B1C3-3EA94B3608B2Q28728804-501ECBC6-F8B5-4C99-8427-AFF29399AAC2Q30407113-61AA637C-29C6-49AB-B2A5-FB4EABC0C2D3Q33623082-EA8C9827-4F89-4DEF-A8E3-242FAFEE8CD1Q33779052-E5798E15-5DAE-48E8-BE5C-3B32E8F5B29AQ33802791-A36FD492-8B9D-40BD-A33E-A2FCF465281BQ34422178-2E5C4696-84E7-4EC6-8F06-771BE48F919BQ34648565-A5E40296-434E-4295-9812-06A3F67DDF78Q34735198-0F1173C9-D3FA-4764-B7D1-87C050E47532Q35152588-0013F57C-AE88-4A49-996B-7A312ACD8294Q35197892-702227F4-87CA-4207-A29F-D7C1DADFA92CQ35200037-1B6B8477-105D-4DDA-819C-8D0B58D36BA3Q35541859-548C7470-1549-4D85-88BA-4F170D482134Q35691185-8F18CC7E-48EF-4080-AD32-40B1D3795593Q35791816-E08EB711-6F1A-4C3F-A030-1996A9439B29Q35801414-6D0DCA0C-2FDF-49B7-A4A9-92A8516D9325Q35860863-7F7B6429-E0E2-4765-BD91-0358D1DB503CQ36099821-664BDF3D-E802-4686-AD3D-3947EE6D8F13Q36146299-D93945E6-60E4-42FC-A253-1EEF19675AB5Q36178225-1723E332-F6E2-4586-A0BB-87EF25E48E24Q36219461-2D52BB57-9605-470A-905A-54F4A0866F15Q36300122-123B5249-A4EC-4579-BFD9-68F25928B612Q36317298-BA30939C-BF11-435B-A5E7-9A6BF2A4FEA1Q36500607-671D10D1-6F76-4E92-8500-824563408FC4Q36747379-7C473CA9-555C-4CE2-956B-C9F85946ADB5Q36780073-7E5E72D1-0C0C-475D-8594-A7A5FB3AA1BEQ36875476-801C5D4A-1C03-4FD4-A5A1-D90C38773A71Q36983845-75E20E19-11BF-4B8F-B7A4-E9B152619125Q37182947-C4F1C314-87D4-4BC7-A6F5-A74DDA0658CCQ37190938-9840B7BE-D919-46E9-8D42-171372126BDEQ37294034-79CDB650-1B7A-4358-B4F8-4F8EE80BB78AQ38123131-FDF3716A-06F1-487C-BCF5-7634DFD08E59Q38568533-7BC1F4F3-7A88-42D8-A4C1-26128AA19290
P2860
Molecular biology of liver ischemia/reperfusion injury: established mechanisms and recent advancements.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Molecular biology of liver isc ...... nisms and recent advancements.
@en
Molecular biology of liver isc ...... nisms and recent advancements.
@nl
type
label
Molecular biology of liver isc ...... nisms and recent advancements.
@en
Molecular biology of liver isc ...... nisms and recent advancements.
@nl
prefLabel
Molecular biology of liver isc ...... nisms and recent advancements.
@en
Molecular biology of liver isc ...... nisms and recent advancements.
@nl
P1476
Molecular biology of liver isc ...... nisms and recent advancements.
@en
P2093
Allan Tsung
John R Klune
P304
P356
10.1016/J.SUC.2010.04.003
P577
2010-08-01T00:00:00Z